<DOC>
	<DOCNO>NCT01009307</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study look blood cheek cell sample patient glioma .</brief_summary>
	<brief_title>Study Blood Cheek Cell Samples From Patients With Glioma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine factor related glioma survival patient two population-based case series collect San Francisco Bay Area August 1991 April 1994 ( series 1 ) May 1997 August 1999 ( series 2 ) . Secondary - Determine vital status 879 patient two San Francisco Bay Area population-based series July 2004 . - Determine survival function establish , potential , yet unstudied prognostic indicator . - Gather data validate result study information adult glioma patient enrol prospectively UCSF-Neuro-Oncology clinic series 3 San Francisco Bay Area Adult Glioma Study ; incorporate result study component SPORE ongoing clinical investigation Brain Tumor Research Center Neuro-Oncology Service UCSF . - Using funding organization Accelerate Brain Cancer Cure ( ABC2 ) , genotype several thousand single nucleotide polymorphism ( SNPs ) study participant ; ass SNPs potential relationship glioma survival . OUTLINE : Medical record patient register California Cancer Registry Northern California Cancer Center SEER review mortality treatment information relate brain tumor . Blood buccal specimen collect patient newly diagnose disease see UCSF Neuro-Oncology Service . The specimen use polymorphism tumor marker study pertinent data . Tumor specimens treatment information relate brain tumor also collect SPORE Tissue Core . Additional tumor maker study , include : chromosome 1p/19q , 7q study ; DNA repair oxidative metabolism polymorphism ; 2 tumor marker 2 constitutive genotyping study .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis glioma Meets 1 follow criterion : Participant Survival study San Francisco Bay Area Adult Glioma Study ( SFBAAGS ) Series 1 2 Treated UCSF NeuroOncology Service ; diagnose Nov. 1 , 2001 June 30 , 2006 see Aug. 1 , 2002 June 30 , 2006 Participant SFBAAGS Series 3 ( see UCSF NeuroOncology Service ) diagnose Nov. 1 , 2001 Oct. 31 , 2004 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult subependymal giant cell astrocytoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult pineal gland astrocytoma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult supratentorial primitive neuroectodermal tumor ( PNET )</keyword>
	<keyword>adult pineoblastoma</keyword>
	<keyword>adult pineocytoma</keyword>
</DOC>